Cirrhosis of the liver
307 results
1 - 100
Cirrhosis of the liver 
Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease- Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease
- Colchicine for primary biliary cirrhosis
- Bezafibrate for primary biliary cirrhosis
- Ursodeoxycholic acid for primary biliary cirrhosis
- Methotrexate for primary biliary cirrhosis
- Alcoholic liver disease (ALD)
- Colchicine for alcoholic and non‐alcoholic liver fibrosis and cirrhosis
- Albumin for people with liver cirrhosis and bacterial infections
- D‐penicillamine for primary biliary cirrhosis
- Model for end stage liver disease for prediction of mortality in people with cirrhosis
- Hormone replacement for osteoporosis in women with primary biliary cirrhosis: Cochrane systematic review
- Glucocorticosteroids for primary biliary cirrhosis
- Human stem cells for decompensated cirrhosis in adults
- Primary sclerosing cholangitis
- Treatment for ascites in adults with decompensated liver cirrhosis: a network meta‐analysis
- Expanded polytetrafluoroethylene (ePTFE)‐covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis
Clinical factors predict death in patients with cirrhosis + UGI bleeding- Cyclosporin A for primary biliary cirrhosis
- Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
- Useful clinical indicators to diagnose cirrhosis
- Bisphosphonates for osteoporosis in primary biliary cirrhosis
- Physical exercise for people with cirrhosis
- Fibrin‐based haemostatic agents for reducing blood loss in adult liver resection
- Surveillance useful for patients with Child-Pugh class B cirrhosis
- Anaemia of chronic disease (ACD)
- Somatostatin analogues for acute bleeding oesophageal varices
- Assessing a patient with an abnormal liver function test result
- Antioxidant supplements for liver diseases
- Autoimmune hepatitis
- Liver and spleen stiffness as assessed by vibration controlled transient elastography for diagnosing clinically significant portal hypertension in comparison with other elastography‐based techniques in adults with chronic liver disease
- Pharmacological interventions for non‐alcohol related fatty liver disease (NAFLD)
- Platelet count/spleen diameter ratio in predicting the presence of oesophageal varices in patients with cirrhosis
- Bile acids for liver‐transplanted patients
- Platelet count, spleen length, and platelet count‐to‐spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
- Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta‐analysis
- Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta‐analysis
- Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta‐analysis
- Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta‐analysis
- Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis: Cochrane systematic review
- Organ transplant recipient in primary health care
- Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis
- Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis
- Primary biliary cholangitis
- Curable causes of cognitive challenges and memory disease
- Chlorambucil for patients with primary biliary cirrhosis: Cochrane systematic review
- Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta‐analysis
- Glucocorticosteroids for primary sclerosing cholangitis: Cochrane systematic review
- Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome
- Vitamin E improves histology of NASH, patient-oriented benefit unknown
- Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis
- Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
- Anabolic‐androgenic steroids for alcoholic liver disease
- Azathioprine for primary biliary cirrhosis
- Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
- Ultrasonographic examinations